by admin | May 29, 2024 | Investment News
Attomarker has been selected as one of the companies by Innovate UK for the following category: GBIP in Hyderabad and Bangalore, India – Antimicrobial Resistance, diagnostics and therapeutics Why India? India has recognised the importance of AMR, and the Indian...
by admin | Nov 29, 2023 | Investment News
We are working with partners to enable early medical intervention for longer, healthier lives for humans and animals. Attomarker Ltd is offering an Advanced Subscription Agreement funding round to support product development, regulatory and roll out. A full set...
by admin | May 4, 2023 | Long Covid, Scientific Announcements
#LongCovid is now affecting over 2 million people in the UK, a “mass disabling event” harming health and livelihoods. In the US, where it is reported over 20 million are afflicted with the condition, Long Covid is being described as the “next public health...
by admin | Jul 27, 2022 | Customer Stories & Cases
Attomarker has partnered with Integra Healthcare in the Cayman Islands, where only 31% of the population has received a boosterdose. The medical team introduced the test to the community with a VIP launch and an informative in-depth article in the Cayman Compass,...
by admin | Jul 27, 2022 | Science
Attomarker technology is a label-free particle plasmon resonance multiplexed array that can measure the concentration quantitatively for up to 20 species in 10 µL blood sample in 7 minutes. The original idea came from a proposal to the Engineering and Physical...
